Assessment of the Efficacy of Topical Ketoconazole 2% Cream in Comparison With Topical Retinoids in the Treatment of Mild Comedonal and Papulopustular Acne
advised to apply topical ketoconazole 2% cream twice daily on the whole face.topical adapalene to the face
advised to apply topical ketoconazole 2% cream twice daily on the whole face.: ketoconazole will be applied twice per day on the face for 12 weeks
topical adapalene to the face: will be advised to apply topical adapalene cream once daily at night on the whole face except sensitive areas for a period of 12 weeks
Study summary
objective: is to assess the efficacy of topical ketoconazole 2% cream in comparison with topical retinoid in the treatment of mild comedonal and papulopustular acne to determine if ketoconazole can be an alternative to topical retinoid with less side effects and more compliance.
Patients and methods: 52 patients with mild comedonal and papulopustular acne will be randomized into 2 groups and instructed to apply randomly either topical KTZ 2% cream or topical retinoid cream for a period of 12 weeks. Evaluation of response will be done by a blinded investigator
Eligibility
Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria:
* Patients with mild comedonal or papulopustular acne with a GEA score from 1-2 on the face.
* Both sexes.
* Age: adolescents and adults.
* Skin type 3 and 4.
Exclusion Criteria:
* • Patients using, will use during the study, or discontinued less than 4 weeks before study baseline, prescribed or over-the counter topical therapies for the treatment of acne.
* Patients using, will use during the study, or discontinued less than 4 weeks before study baseline, any facial procedures such as chemical peel, laser treatment or depilation in area of treatment application (except eyebrow shaping).
* Patients with outdoor occupation, exposed to sun and heat.
* Patients using, will use during study any cosmoceuticals.
* Patients using, will use during the study, or discontinued less than 12 weeks before study baseline, systemic therapies for the treatment of acne or any other systemic treatments.
* Patients with other special types of acne or conditions presenting with acne/acneiform eruption.
* Irregular menstrual cycles or clinically suspected polycystic ovarian syndrome.
* Patients with other facial rashes preventing the accurate assessment.
* Known or suspected allergy to ingredients.
* Pregnancy or lactation.
Primary outcome measure(s)
To study the efficacy of topical ketoconazole 2% cream in treatment of mild to moderate acne — 3 months results will be assessed using total lesion count
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
We use cookies to analyse site traffic and improve your experience. With your consent, we may also use cookies for advertising. You can change your choice at any time.